Published in Genetics and Environmental Business Week, January 26th, 2006
Revlimid will be available through a Revlimid education and prescribing safety program, called RevAssist, via contracted pharmacies.
"The clinical data from a phase II trial of 148 patients demonstrated that Revlimid can reduce or even eliminate the need for transfusions in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week